Skip to contentA
Accendra Health Inc
A
ACHAccendra Health Inc Q2 2019 · 10-Q
Revenue$2.38B$2.38B−3.3% vs Q2 2018 Net Income-$10.48M-$10.48MN/M vs Q2 2018 EPS Diluted-$0.17-$0.17N/M vs Q2 2018 Gross Profit$286,518,000−11.8% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Accendra Health Inc · CIK 75252 · Engraved from SEC EDGAR
Operating Cash Flowderived$89,918,000+221.4% Free Cash Flowderived$80,572,000+428.8% Margins · derivedGross margin12.1%−1.2 pt vs Q2 2018
Operating margin0.7%+7.7 pt vs Q2 2018
Net margin-0.4%+7.0 pt vs Q2 2018
ended Jun 30, 2019 · filed Aug 7, 2019 · 38 d after period end